Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1999 Sep-Oct;5(5):659–671. doi: 10.3201/eid0505.990507

The economic impact of pandemic influenza in the United States: priorities for intervention.

M I Meltzer 1, N J Cox 1, K Fukuda 1
PMCID: PMC2627723  PMID: 10511522

Abstract

We estimated the possible effects of the next influenza pandemic in the United States and analyzed the economic impact of vaccine-based interventions. Using death rates, hospitalization data, and outpatient visits, we estimated 89,000 to 207,000 deaths; 314,000 to 734,000 hospitalizations; 18 to 42 million outpatient visits; and 20 to 47 million additional illnesses. Patients at high risk (15% of the population) would account for approximately 84% of all deaths. The estimated economic impact would be US$71.3 to $166.5 billion, excluding disruptions to commerce and society. At $21 per vaccinee, we project a net savings to society if persons in all age groups are vaccinated. At $62 per vaccinee and at gross attack rates of 25%, we project net losses if persons not at high risk for complications are vaccinated. Vaccinating 60% of the population would generate the highest economic returns but may not be possible within the time required for vaccine effectiveness, especially if two doses of vaccine are required.

Full Text

The Full Text of this article is available as a PDF (197.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker W. H. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health. 1986 Jul;76(7):761–765. doi: 10.2105/ajph.76.7.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barker W. H., Mullooly J. P. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol. 1980 Dec;112(6):798–811. doi: 10.1093/oxfordjournals.aje.a113052. [DOI] [PubMed] [Google Scholar]
  3. Barker W. H., Mullooly J. P. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med. 1982 Jan;142(1):85–89. [PubMed] [Google Scholar]
  4. Campbell D. S., Rumley M. H. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Med. 1997 May;39(5):408–414. doi: 10.1097/00043764-199705000-00006. [DOI] [PubMed] [Google Scholar]
  5. Carrat F., Valleron A. J. Influenza mortality among the elderly in France, 1980-90: how many deaths may have been avoided through vaccination? J Epidemiol Community Health. 1995 Aug;49(4):419–425. doi: 10.1136/jech.49.4.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cliff A. D., Haggett P. Statistical modelling of measles and influenza outbreaks. Stat Methods Med Res. 1993;2(1):43–73. doi: 10.1177/096228029300200104. [DOI] [PubMed] [Google Scholar]
  7. Fox J. P., Hall C. E., Cooney M. K., Foy H. M. Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol. 1982 Aug;116(2):212–227. doi: 10.1093/oxfordjournals.aje.a113407. [DOI] [PubMed] [Google Scholar]
  8. Glezen W. P., Decker M., Joseph S. W., Mercready R. G., Jr Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. J Infect Dis. 1987 Jun;155(6):1119–1126. doi: 10.1093/infdis/155.6.1119. [DOI] [PubMed] [Google Scholar]
  9. Glezen W. P., Payne A. A., Snyder D. N., Downs T. D. Mortality and influenza. J Infect Dis. 1982 Sep;146(3):313–321. doi: 10.1093/infdis/146.3.313. [DOI] [PubMed] [Google Scholar]
  10. Kaufmann A. F., Meltzer M. I., Schmid G. P. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis. 1997 Apr-Jun;3(2):83–94. doi: 10.3201/eid0302.970201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kavet J. A perspective on the significance of pandemic influenza. Am J Public Health. 1977 Nov;67(11):1063–1070. doi: 10.2105/ajph.67.11.1063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McBean A. M., Babish J. D., Warren J. L. The impact and cost of influenza in the elderly. Arch Intern Med. 1993 Sep 27;153(18):2105–2111. [PubMed] [Google Scholar]
  13. Patriarca P. A., Arden N. H., Koplan J. P., Goodman R. A. Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine. Ann Intern Med. 1987 Nov;107(5):732–740. doi: 10.7326/0003-4819-107-5-732. [DOI] [PubMed] [Google Scholar]
  14. Riddiough M. A., Sisk J. E., Bell J. C. Influenza vaccination. JAMA. 1983 Jun 17;249(23):3189–3195. [PubMed] [Google Scholar]
  15. Schoenbaum S. C., McNeil B. J., Kavet J. The swine-influenza decision. N Engl J Med. 1976 Sep 30;295(14):759–765. doi: 10.1056/NEJM197609302951405. [DOI] [PubMed] [Google Scholar]
  16. Serfling R. E., Sherman I. L., Houseworth W. J. Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957-58, 1960 and 1963. Am J Epidemiol. 1967 Sep;86(2):433–441. doi: 10.1093/oxfordjournals.aje.a120753. [DOI] [PubMed] [Google Scholar]
  17. Simonsen L., Clarke M. J., Schonberger L. B., Arden N. H., Cox N. J., Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998 Jul;178(1):53–60. doi: 10.1086/515616. [DOI] [PubMed] [Google Scholar]
  18. Simonsen L., Clarke M. J., Williamson G. D., Stroup D. F., Arden N. H., Schonberger L. B. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 1997 Dec;87(12):1944–1950. doi: 10.2105/ajph.87.12.1944. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES